AGA Backs Fecal Microbiota-Based Therapies for Recurrent C.

But new guidelines do not recommend use in inflammatory bowel disease or irritable bowel syndrome

Related Keywords

United States , Boston , Massachusetts , American , Katherine Kahn , Anne Peery , Colleen Kelly , Harvard Medical School , American Gastroenterological Association , University Of North Carolina At Chapel Hill , North Carolina , Chapel Hill , Medpage Today , Gastroenterological Association , Irritable Bowel , Irritable Bowel Syndrome , Inflammatory Bowel Disease , Recurrent , Megacolon ,